Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus

Vaccine

Volumn 27, Issue 32, 2009, Pages 4350-4354

  Sirikwin, Siriwan ^a   Likanonsakul, Sirirat ^a   SimakanWaradejwinyoo, ^a   Pattamadilok, Sirima ^a   Kumperasart, Sanit ^a   Chaovavanich, Achara ^a   Manatsathit, Sathaporn ^b   Malerczyk, Claudius ^c   Wasi, Chantapong ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Novartis Vaccine   (Germany)

Author keywords

HIV AIDS; Intradermal; Neutralizing antibody; PCECV; Rabies; Vaccination

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABIES; RABIES VIRUS; VACCINATION; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PROSPECTIVE STUDIES; RABIES; RABIES VACCINES; VACCINATION; VIRAL LOAD; YOUNG ADULT;

EID: 67649505405     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.027     Document Type: Article

References (25)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fèvre E.M., Meltzer M.I., Miranda M.E., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83 (2005) 360-383
2. WHO. Rabies vaccines. Week Epidemiol Rec 77 14 (2002) 109-120
3. Hemachudha T. Rabies and dog population control in Thailand: success or failure?. J Med Assoc Thai 88 (2005) 120-123
4. Bureau of Epidemiology, Department of Disease Control. Annual epidemiological surveillance report. Nonthaburi: Ministry of Public Health; 1997-2006 [in Thai].
5. WHO. WHO Expert Consultation on Rabies. WHO Tech Rep Ser 931. Geneva: World Health Organization; 2004.
6. WHO. Intradermal application of rabies vaccines. Report of a WHO Consultation, Communicable Disease Surveillance and Control. WHO/CDS/CSR/APH/2000.5, Bangkok, Thailand; 2000.
7. Bureau of Epidemiology, Dept. of Disease Control, Ministry of Public Health, Thailand. Annual epidemiological surveillance report, ; 2006 [accessed 15.09.08].
8. Warrell M.J., Suntharasamai P., Nicholson K.G., Warrell D.A., Chanthavanich P., Viravan C., et al. Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens. Lancet 1 8382 (1984) 874-876
9. Scheiermann N., Baer J., Hilfenhaus J., Marcus I., and Zoulek G. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man. Zentralbl Bakteriol Mikrobiol Hyg [A] 265 3-4 (1987) 439-450
10. Vodopija I., Sureau P., Lafon M., Baklaic Z., Ljubicić M., Svjetlicić M., et al. An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule. Vaccine 4 4 (1986) 245-248
11. Nicholson K.G., Farrow P.R., Bijok U., and Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine 5 3 (1987) 208-210
12. Briggs D.J., Banzhoff A., Nicolay U., Sirikwin S., Dumavibhat B., Tongswas S., et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 78 5 (2000) 693-698
13. Madhusudana S.N., Anand N.P., and Shamsundar R. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals. Int J Infect Dis 6 (2002) 210-214
14. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., and Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0,1 mL PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 23 14 (2005) 1709-1714
15. Kamoltham T., Thinyounyong W., Phongchamnaphai P., Phraisuwan P., Khawplod P., Banzhoff A., et al. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. J Pediatr 151 2 (2007) 173-177
16. Thisyakorn U., Pancharoen C., and Wilde H. Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination. Vaccine 19 11-12 (2001) 1534-1537
17. Jaijaroensup W., Tantawichien T., Khawplod P., Tepsumethanon S., and Wilde H. Post-exposure Rabies vaccination in patients infected with Human Immunodeficiency Virus. Clin Infect Dis 28 (1999) 913-914
18. Pancharoen C., Thisyakorn U., Tantawichien T., Jaijaroensup W., Khawplod P., and Wilde H. Failure of pre- and postexposure rabies vaccination in a child infected with HIV. Scand J Infect Dis 33 5 (2001) 390-391
19. Tantawichien T., Jaijaroensup W., Khawplod P., and Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin Infect Dis 33 10 (2001) E122-E124
20. Sirikwin S., Pattamadilok S., Likanonsakul S., Kamperasart S., and Punyabaramee W. Post-exposure rabies prophylaxis in HIV infected patients. Dis Control J 29 2 (2003) 99-103
21. Smith J.S., Yager P.A., and Baer G.M. A rapid tissue culture test for determining rabies neutralizing antibody. WHO Monogr Ser 23 (1973) 354-357
22. Thisyakorn U., Pancharoen C., Ruxrungtham K., Ubolyam S., Khawplod P., Tantawichien T., et al. Safety and immunogenicity of pre-exposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin Infect Dis 30 1 (2000) 218
23. Donovan R.M., Moore E., Bush C.E., Markowitz N.P., and Saravolatz L.D. Change in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS 11 8 (1997) 1054-1056
24. Nicolas J.F., and Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Exp Rev Vac 7 8 (2008) 1201-1214
25. Mallewa M., Fooks A.R., Banda D., Chikungwa P., Mankhambo L., Molyneux E., et al. Rabies encephalitis in malaria-endemic area, Malawi, Africa. Emerg Infect Dis 13 1 (2007) 136-139